Skip to content
★ Sign in to follow
EMVision Medical Devices Ltd logo

EMVision Medical Devices Ltd Stock: price and insider trades · Australia

AU·Mcap A$145.5MHealth Care

No insider purchase over the last 90 days. The latest, by Carmel Monaghan, was filed 23 Apr 2026.

EMVision Medical Devices Ltd: what insiders have been doing

Only a handful of insider records exist for EMVision Medical Devices Ltd, the last one from 23 April 2026, too few to describe a trend. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.

Insider Decl.
1
Thresholds
n/a
Buy Volume
€11,293
1 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Carmel Monaghan1 buy

Since the insiders bought

  • Filed 23 Apr 2026 · 200 days ago · €11k
    -15.2%
    Entry A$1.74 · Close at T+90 A$1.48

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$1.57
Analyst consensus
1 analysts
1.00/5
A$3.15Target A$3.15(+101%)A$3.15
Income statement
EBITDA-A$7.7M
Net income-A$8.3M-99.5% margin
Valuation
PER (forward)-12.0x
P/Book9.2x
Beta1.10
Balance sheet & cash
Market capA$145.5M
Total debtA$3.4M
Free Cash Flow-A$6.4M
Debt / Equity22%
Profitability & ownership
ROE-66.4%
ROA-27.8%
% insiders33.7%
% institutions3.6%
Last declaration on 23 April 2026
Declarations1 total
  • ▲
    DirectorExecutives
    18,470 AUD19ASX
    10,000 shares@ A$1.8470.011% mcap100.0% of flowShareASXASX:2924-03082181-6A1321889
    Canonical exit: 21 Jul 2026 (T+90)

1 of 1 declaration

About EMVision Medical Devices Ltd

EMV is a company in the healthcare and pharmaceutical sector, listed on the XASX market. It specializes in developing innovative solutions to enhance healthcare.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations